Integration of HIV and cervical cancer screening perceptions of healthcare providers and policy makers in Uganda

BMC Public Health

Vanja Berggren³  Henry Wabinga²  Sören Andersson¹  Edward Kumakech² 

[1] Department of Laboratory Medicine, Örebro University Hospital, Örebro, Sweden;Department of Pathology, Makerere University, College of Health Sciences, Kampala, Uganda;Division of Health Sciences, Lund University, Lund, Sweden

关键词: Uganda;    Integration;    Screening;    Cervical cancer;    HIV;   

Others  :  1128744
DOI  :  10.1186/1471-2458-14-810

 received in 2014-01-10, accepted in 2014-07-10,  发布年份 2014

【 摘 要 】

Background

HIV-positive women have an increased risk of developing cervical cancer (CC) compared to the HIV-negative women. Despite this, HIV and CC screening programs in many developing countries have remained disintegrated. Therefore, the objective of the study was to explore perceptions of healthcare providers (HCP) and policy makers (PM) about integration of HIV and CC screening services in Uganda.

Methods

This was a qualitative study conducted among 16 participants comprising of 12 healthcare providers and 4 policy makers in Uganda. Data were collected through individual interviews. Participants were purposively selected from different level of health facilities with clinics for HIV and CC screening services. Content analysis method was used to analyze the data.

Results

Three themes emerged from the data, namely appreciating benefits of integration, worrying about the limited health system capacity and potential consequences of integration and feeling optimistic about integration under improved health system conditions. The benefits embraced the women – particularly the HIV-positive women- but also men, healthcare providers and the health system or the government. There were worries that HIV stigma and shortage of healthcare workers would affect the effective delivery of the integrated program.

Conclusion

Integration of HIV and CC screening can offer manifold benefits to all stakeholders in the health system, more so to the women. However, its feasibility in developing countries such as Uganda will most likely be hampered by weak and inefficient health systems. Therefore, when considering HIV and CC screening integration, it is important not to only recognize the benefits but also take into account resources requirements for addressing the existing weaknesses and inefficiencies in the health systems such as limited infrastructure, insufficient drugs and supplies, inadequate and poorly motivated healthcare workers.

【 授权许可】

   
2014 Kumakech et al.; licensee BioMed Central Ltd.

【 图 表 】

Figure 1.

【 参考文献 】

• [1]International Agency for Research on Cancer (IARC): Cancer Incidence in 5 Continents, 2008, vol IX. Lyon: IARC Press; Globocan; 2008. Available at http://globocan.iarc.fr/Pages/fact_sheets_population.aspx webcite
• [2]Parkin DM, Bray F, Ferlay J, Pisani P: Global cancer statistics, 2002. CA Cancer J Clin 2005, 55(2):74-108.
• [3]Wabinga HR, Parkin DM, Wabwire-Mangen F, Nambooze S: Trends in cancer incidence in Kyadondo County, Uganda, 1960–1997. Br J Cancer 2000, 82(9):1585-1592.
• [4]Zorrilla C, Romaguera J, Corrada R: Increased expression of HPV and cervical dysplasia in women with HIV infection (abstract). 13th Congress of FIGO. Int J Obstet Gynecol 1991., 142
• [5]Odida M, Sandin S, Mirembe F, Kleter B, Quint W, Weiderpass E: HPV types, HIV and invasive cervical carcinoma risk in Kampala, Uganda: a case–control study. Infect Agent Cancer 2011, 6:8. BioMed Central Full Text
• [6]Rabkin CS, Biggar RJ, Baptiste MS, Abe T, Kohler BA, Nasca PC: Cancer incidence trends in women at high risk of human immunodeficiency virus (HIV) infection. Int J Cancer 1993, 55:208-212.
• [7]Hawes SE, Critchlow CW, Faye Niang MA, Diouf MB, Diop A, Touré P, Aziz Kasse A, Dembele B, Salif Sow P, Coll-Seck AM, Kuypers JM, Kiviat NB: Increased risk of high-grade cervical squamous intraepithelial lesions and invasive cervical cancer among African women with human immunodeficiency virus type 1 and 2 infections. J Infect Dis 2003, 188:555-563.
• [8]Gichangi PB, Bwayo J, Estambale B, De Vuyst H, Ojwang S, Rogo K, Abwao H, Temmerman M: Impact of HIV infection on invasive cervical cancer in Kenyan women. AIDS 2003, 17:1963-1968.
• [9]World Health Organization (WHO): Comprehensive Cervical Cancer Control, A Guide to Essential Practice. Geneva: WHO Press; 2000.
• [10]Munoz N, Castellsague X, de Gonzalez AB, Gissmann L: Chapter 1: HPV in the etiology of human cancer. Vaccine 2006, 24(Supplement 3):S1-S10.
• [11]Walboomers JM, Jacobs MV, Manos MM: Human papillomavirus is a necessary cause of invasive cervical cancer worldwide. J Pathol 1999, 189(1):12-19.
• [12]Banura C, Mirembe FM, Katahoire AR, Namujju PB, Mbonye AK, Wabwire FM: Epidemiology of HPV genotypes in Uganda and the role of the current preventive vaccines: A systematic review. Infect Agent Cancer 2011, 6:11. BioMed Central Full Text
• [13]Zango A, Dubé K, Kelbert S, Meque I, Cumbe F, Chen PL, Ferro JJ, Feldblum PJ, van de Wijgert J: Determinants of prevalent HIV infection and late HIV diagnosis among young women with two or more sexual partners in Beira, Mozambique. PLoS One 2013, 8(5):e63427.
• [14]Kasamba I, Sully E, Weiss HA, Baisley K, Maher D: Extra-spousal partnerships in a community in rural Uganda with high HIV prevalence: a cross-sectional population-based study using linked spousal data. J Acquir Immune Defic Syndr 2011, 58(1):108-114.
• [15]Kahesa C, Mwaiselage J, Wabinga HR, Ngoma T, Kalyango JN, Karamagi CAS: Association between invasive cancer of the cervix and HIV-1 infection in Tanzania: the need for dual screening. BMC Public Health 2008, 8:262. BioMed Central Full Text
• [16]Chiao EY, Dezube BJ, Krown SE, Wachsman W, Brock M, Giordano TP, Mitsuyasu R, Pantanowitz L: Time for oncologists to opt-in for routine opt-out HIV testing? JAMA 2010, 304(3):334-339.
• [17]Mwanahamuntu MH, Sahasrabuddhe VV, Kapambwe S, Pfaendler KS, Chibwesha C: Advancing cervical cancer prevention initiatives in resource-constrained settings: insights from the Cervical Cancer Prevention Program in Zambia. PLoS Med 2011, 8(5):e1001032.
• [18]Were E, Nyaberi Z, Buziba N: Integrating cervical cancer and genital tract infection screening into mother, child health and family planning clinics in Eldoret, Kenya. Afr Health Sci 2010, 10(1):58-65.
• [19]Ezechi OC, Gab-Okafor CV, Ostergren PO, Odberg Pettersson K: Willingness and acceptability of cervical cancer screening among HIV positive Nigerian women. BMC Public Health 2013, 13:46. BioMed Central Full Text
• [20]Odafe S, Torpey K, Khamofu H, Oladele E, Adedokun O, Chabikuli O, Mukaddas H, Usman Y, Aiyenigba B, Okoye M: Integrating cervical cancer screening with HIV care in a district hospital in Abuja, Nigeria. Niger Med J 2013, 54(3):176-184.
• [21]Sandelowski M: Whatever happened to qualitative description? Res Nurs Health 2000, 23:334-340.
• [22]Corbin J, Morse JM: The unstructured interactive interview: issues of reciprocity and risks when dealing with sensitive topics. Qual Inq 2003, 9(3):335-354.
• [23]Polit DE, Beck CT: Essentials of Nursing Research: Methods, Appraisal and Utilization 6th ed. Philadelphia: Lippincott Williams and Wilkins; 2006.
• [24]Clark H, Taplin D: Theory of Change Basics: A Primer on Theory of Change. New York: Actknowledge; 2012.
• [25]Graneheim U, Lundman B, Qualitative content analysis in nursing research: Concepts, procedures and measures to achieve trustworthiness. Nurse Educ Today 2004, 24:105-112.
• [26]Clark JP: How to peer review a qualitative manuscript. In Peer Review in Health Sciences. Second edition. Edited by Godlee F, Jefferson T. London: BMJ Books; 2003:219-235.
• [27]Moon TD, Silva-Matos C, Cordoso A, Baptista AJ, Sidat M, Vermund SH: Implementation of cervical cancer screening using visual inspection with acetic acid in rural Mozambique: successes and challenges using HIV care and treatment programme investments in Zambézia Province. J Int AIDS Soc 2012, 15(2):17406.
• [28]Polit DF, Hungler BP: Nursing Research Principles and Methods (6th edition). Philadelphia: Lippincott; 1995.